Results: 76.2% of patients achieved a complete response, 13.6% of patients stabilized; disease control rate reached 89.8%. The response rate for each type of lesion was as follows: Primary lung tumor (68.5%); contralateral lung metastases (65.3%); central nervous system metastasis (80%); adrenal metastases (66.7%); liver metastases (71.4%).